Nova Anchora

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.novaanchora.com/

Last Round

Seed

Apr 29, 2025

Company Overview

Nova Anchora is a biotechnology company developing corrective protein therapies for dystrophic epidermolysis bullosa.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaldystrophic epidermolysis bullosaDEBrecombinant protein therapyrare diseaseorphan drugtopical therapygenetic skin disordertype VII collagenbiotechpreclinical developmentdrug discoverybutterfly skinIND-enabling studies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nova Anchora Comparables

Compare Nova Anchora with similar companies based on industry and business-model similarity.

Nova Anchora comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Phoenicis Therapeutics	84%
BridgeBio Pharma, Inc.	82%
Aegle Therapeutics Corp	81%

View all Comparables

Nova Anchora Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Apr 29, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Jason Bhardwaj

CEO

Executive Team

Nova Anchora Investors

Notable investors and investment history

Nova Anchora investors
Investor	Rounds
Viking Global Investors	Seed
DEBRA Research gGmbH	Seed

View all Investors

Nova Anchora Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Nova Anchora Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nova Anchora's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range2

Year Founded2021

Last FundingApr 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?